vs

Side-by-side financial comparison of Namib Minerals (NAMM) and SBC Medical Group Holdings Inc (SBC). Click either name above to swap in a different company.

Namib Minerals is the larger business by last-quarter revenue ($41.9M vs $39.6M, roughly 1.1× SBC Medical Group Holdings Inc). SBC Medical Group Holdings Inc produced more free cash flow last quarter ($51.2M vs $7.4M).

Namib Minerals is a Namibia-based natural resources firm focused on exploration, development and extraction of high-demand mineral deposits including uranium, copper and lithium. It operates across licensed southern African sites, supplying raw materials to global clean energy, construction and electronics manufacturing sectors.

SBC Medical Group Holdings Inc. is a leading Japan-headquartered healthcare provider primarily focused on aesthetic medicine, dermatology, and anti-aging wellness services. It operates an extensive network of clinics across Japan, catering to both domestic patients and international medical tourists, with core offerings including cosmetic surgery and non-invasive skincare treatments.

NAMM vs SBC — Head-to-Head

Bigger by revenue
NAMM
NAMM
1.1× larger
NAMM
$41.9M
$39.6M
SBC
More free cash flow
SBC
SBC
$43.8M more FCF
SBC
$51.2M
$7.4M
NAMM

Income Statement — Q2 FY2025 vs Q4 FY2025

Metric
NAMM
NAMM
SBC
SBC
Revenue
$41.9M
$39.6M
Net Profit
$14.2M
Gross Margin
45.7%
73.1%
Operating Margin
29.8%
32.5%
Net Margin
35.9%
Revenue YoY
-10.9%
Net Profit YoY
117.2%
EPS (diluted)
$0.15

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NAMM
NAMM
SBC
SBC
Q4 25
$39.6M
Q3 25
$43.4M
Q2 25
$41.9M
$43.4M
Q1 25
$47.3M
Q4 24
$44.4M
Q3 24
$53.1M
Q2 24
$53.1M
Q1 24
$54.8M
Net Profit
NAMM
NAMM
SBC
SBC
Q4 25
$14.2M
Q3 25
$12.8M
Q2 25
$2.5M
Q1 25
$21.5M
Q4 24
$6.5M
Q3 24
$2.8M
Q2 24
$18.5M
Q1 24
$18.8M
Gross Margin
NAMM
NAMM
SBC
SBC
Q4 25
73.1%
Q3 25
70.6%
Q2 25
45.7%
69.2%
Q1 25
79.7%
Q4 24
76.3%
Q3 24
81.5%
Q2 24
74.2%
Q1 24
72.1%
Operating Margin
NAMM
NAMM
SBC
SBC
Q4 25
32.5%
Q3 25
36.6%
Q2 25
29.8%
33.6%
Q1 25
51.1%
Q4 24
10.6%
Q3 24
26.1%
Q2 24
51.4%
Q1 24
44.6%
Net Margin
NAMM
NAMM
SBC
SBC
Q4 25
35.9%
Q3 25
29.6%
Q2 25
5.7%
Q1 25
45.4%
Q4 24
14.7%
Q3 24
5.3%
Q2 24
34.8%
Q1 24
34.2%
EPS (diluted)
NAMM
NAMM
SBC
SBC
Q4 25
$0.15
Q3 25
$0.12
Q2 25
$0.02
Q1 25
$0.21
Q4 24
$0.05
Q3 24
$0.03
Q2 24
$0.20
Q1 24
$0.20

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NAMM
NAMM
SBC
SBC
Cash + ST InvestmentsLiquidity on hand
$164.1M
Total DebtLower is stronger
$42.8M
Stockholders' EquityBook value
$248.3M
Total Assets
$380.4M
Debt / EquityLower = less leverage
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NAMM
NAMM
SBC
SBC
Q4 25
$164.1M
Q3 25
$127.4M
Q2 25
$152.7M
Q1 25
$132.1M
Q4 24
$125.0M
Q3 24
$137.4M
Q2 24
Q1 24
Total Debt
NAMM
NAMM
SBC
SBC
Q4 25
$42.8M
Q3 25
$21.1M
Q2 25
$7.1M
Q1 25
$6.9M
Q4 24
$6.6M
Q3 24
$823.2K
Q2 24
Q1 24
Stockholders' Equity
NAMM
NAMM
SBC
SBC
Q4 25
$248.3M
Q3 25
$248.0M
Q2 25
$244.6M
Q1 25
$226.4M
Q4 24
$195.1M
Q3 24
$205.0M
Q2 24
$8.8M
Q1 24
$9.0M
Total Assets
NAMM
NAMM
SBC
SBC
Q4 25
$380.4M
Q3 25
$321.4M
Q2 25
$315.3M
Q1 25
$284.6M
Q4 24
$266.1M
Q3 24
$296.5M
Q2 24
$19.5M
Q1 24
$19.8M
Debt / Equity
NAMM
NAMM
SBC
SBC
Q4 25
0.17×
Q3 25
0.09×
Q2 25
0.03×
Q1 25
0.03×
Q4 24
0.03×
Q3 24
0.00×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NAMM
NAMM
SBC
SBC
Operating Cash FlowLast quarter
$11.4M
$52.0M
Free Cash FlowOCF − Capex
$7.4M
$51.2M
FCF MarginFCF / Revenue
17.6%
129.3%
Capex IntensityCapex / Revenue
9.6%
2.0%
Cash ConversionOCF / Net Profit
3.66×
TTM Free Cash FlowTrailing 4 quarters
$23.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NAMM
NAMM
SBC
SBC
Q4 25
$52.0M
Q3 25
$-20.9M
Q2 25
$11.4M
$-8.3M
Q1 25
$1.9M
Q4 24
$-7.3M
Q3 24
$5.0M
Q2 24
$19.2M
Q1 24
$3.7M
Free Cash Flow
NAMM
NAMM
SBC
SBC
Q4 25
$51.2M
Q3 25
$-20.9M
Q2 25
$7.4M
$-8.6M
Q1 25
$1.7M
Q4 24
$-7.9M
Q3 24
$4.6M
Q2 24
$18.3M
Q1 24
$3.0M
FCF Margin
NAMM
NAMM
SBC
SBC
Q4 25
129.3%
Q3 25
-48.3%
Q2 25
17.6%
-19.9%
Q1 25
3.5%
Q4 24
-17.8%
Q3 24
8.7%
Q2 24
34.5%
Q1 24
5.4%
Capex Intensity
NAMM
NAMM
SBC
SBC
Q4 25
2.0%
Q3 25
0.1%
Q2 25
9.6%
0.7%
Q1 25
0.5%
Q4 24
1.3%
Q3 24
0.8%
Q2 24
1.6%
Q1 24
1.3%
Cash Conversion
NAMM
NAMM
SBC
SBC
Q4 25
3.66×
Q3 25
-1.63×
Q2 25
-3.39×
Q1 25
0.09×
Q4 24
-1.12×
Q3 24
1.77×
Q2 24
1.04×
Q1 24
0.20×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

NAMM
NAMM

Segment breakdown not available.

SBC
SBC

Franchising$10.3M26%
Medical Corporation Shobikai$8.1M21%
Medical Corporation Nasukai$7.2M18%
Management Services$6.3M16%
Rental Services$4.3M11%
Medical Corporation Association Furinkai$3.0M8%
Japan Medical And Beauty Inc$656.5K2%

Related Comparisons